Real-World Analysis of Opioid Use in Patients With Fibromyalgia Presented at ASCP 2026 Key Takeaways Retrospective analysis of Symphony Health closed claims required 3-year continuous coverage and identified 261,776 fibromyalgia patients in 2023–2024, predominantly female, mean age 52.3 years. Opioid exposure remained high across payers, affecting 40.2% of commercial/Medicare Advantage and 38.8% of Medicaid patients with fibromyalgia during the observation period. A new real-world claims analysis of opioid use in patients with fibromyalgia was presented by Tonix Pharmaceuticals at this year’s meeting of the American Society for Clinical Psychopharmacology.1 Data showed…
Read MoreReal-World Analysis of Opioid Use in Patients With Fibromyalgia Presented at ASCP 2026
